Aspergillus Species in Lower Respiratory Tract of Hospitalized Patients from Shanghai, China: Species Diversity and Emerging Azole Resistance

References

• Samson RA, Visagie CM, Houbraken J, et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud Mycol. 2014;78:141–173. doi:10.1016/j.simyco.2014.07.00425492982
   PubMed Web of Science ®Google Scholar
• Park HS, Jun SC, Han KH, Hong SB, Yu JH. Diversity, application, and synthetic biology of industrially important Aspergillus fungi. Adv Appl Microbiol. 2017;100:161–202.28732553
   PubMed Web of Science ®Google Scholar
• Shishodia SK, Tiwari S, Shankar J. Resistance mechanism and proteins in Aspergillus species against antifungal agents. Mycology. 2019;10(3):151–165. doi:10.1080/21501203.2019.157492731448149
   PubMed Web of Science ®Google Scholar
• Sugui JA, Kwon-Chung KJ, Juvvadi PR, Latge JP, Steinbach WJ. Aspergillus fumigatus and related species. Cold Spring Harb Perspect Med. 2014;5(2):a019786. doi:10.1101/cshperspect.a01978625377144
   PubMed Web of Science ®Google Scholar
• Yii AC, Koh MS, Lapperre TS, Tan GL, Chotirmall SH. The emergence of Aspergillus species in chronic respiratory disease. Front Biosci (Schol Ed). 2017;9:127–138. doi:10.2741/s47727814579
   PubMedGoogle Scholar
• Siqueira JP, Sutton DA, Garcia D, et al. Species diversity of Aspergillus section Versicolores in clinical samples and antifungal susceptibility. Fungal Biol. 2016;120(11):1458–1467. doi:10.1016/j.funbio.2016.02.00627742099
   PubMed Web of Science ®Google Scholar
• Latge JP, Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clin Microbiol Rev. 2019;33(1).
   Web of Science ®Google Scholar
• Gago S, Denning DW, Bowyer P. Pathophysiological aspects of Aspergillus colonization in disease. Med Mycol. 2019;57(Supplement_2):S219–S227. doi:10.1093/mmy/myy07630239804
   PubMed Web of Science ®Google Scholar
• Ohara S, Tazawa Y, Tanai C, et al. Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: comparison of chronic pulmonary aspergillosis and colonization. Respir Investig. 2016;54(2):92–97. doi:10.1016/j.resinv.2015.08.007
   Google Scholar
• Dimopoulos G, Frantzeskaki F, Poulakou G, Armaganidis A. Invasive aspergillosis in the intensive care unit. Ann N Y Acad Sci. 2012;1272(1):31–39. doi:10.1111/j.1749-6632.2012.06805.x23231712
   PubMed Web of Science ®Google Scholar
• Darling BA, Milder EA. Invasive aspergillosis. Pediat Rev. 2018;39(9):476–478. doi:10.1542/pir.2017-0129
   Web of Science ®Google Scholar
• Giray B, Kocaogut E, Bu F, Haliki-Uztan A. Genotypic discrimination of Aspergillus fumigatus strain from related species within section fumigati. Ann Agric Environ Med. 2016;23(3):448–451.27660866
   PubMed Web of Science ®Google Scholar
• Gautier M, Normand AC, Ranque S. Previously unknown species of Aspergillus. Clin Microbiol Infect. 2016;22(8):662–669. doi:10.1016/j.cmi.2016.05.01327263029
   PubMed Web of Science ®Google Scholar
• Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis. 2016;62(3):362–368. doi:10.1093/cid/civ88526486705
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(suppl_3):S436–S444. doi:10.1093/infdis/jix21028911045
   PubMed Web of Science ®Google Scholar
• Alastruey-Izquierdo A, Mellado E, Cuenca-Estrella M. Current section and species complex concepts in Aspergillus: recommendations for routine daily practice. Ann N Y Acad Sci. 2012;1273:18–24. doi:10.1111/j.1749-6632.2012.06822.x23230833
   PubMed Web of Science ®Google Scholar
• Li Y, Wan Z, Liu W, Li R, Warnock DW. Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins. J Clin Microbiol. 2015;53(2):702–705. doi:10.1128/JCM.03233-1425502526
   PubMed Web of Science ®Google Scholar
• Chen M, Xu Y, Hong N, et al. Epidemiology of fungal infections in China. Front Med. 2018;12(1):58–75.29380297
   PubMed Web of Science ®Google Scholar
• Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63(4):e1–e60.27365388
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. Lancet. 2002;359(9312):1135–1144. doi:10.1016/S0140-6736(02)08162-X11943280
   PubMed Web of Science ®Google Scholar
• Pérez-Cantero A, López-Fernández L, Guarro J, Capilla J. Azole resistance mechanisms in Aspergillus: update and recent advances. Int J Antimicrob Agents. 2020;55(1):105807. doi:10.1016/j.ijantimicag.2019.09.01131542320
   PubMed Web of Science ®Google Scholar
• Vermeulen E, Maertens J, Schoemans H, Lagrou K. Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill. 2012;17(48):20326.23218390
   PubMedGoogle Scholar
• Verweij PE, Mellado E, Melchers WJ. Multiple-triazole-resistant aspergillosis. N Engl J Med. 2007;356(14):1481–1483. doi:10.1056/NEJMc061720
   PubMed Web of Science ®Google Scholar
• Meis JF, Chowdhary A, Rhodes JL, Fisher MC, Verweij PE. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Philos Trans R Soc. 2016;371(1709):20150460.
   Web of Science ®Google Scholar
• Chen Y, Wang H, Lu Z, et al. Emergence of TR46/Y121F/T289A in an Aspergillus fumigatus isolate from a Chinese patient. Antimicrob Agents Chemother. 2015;59(11):7148–7150. doi:10.1128/AAC.00887-1526282417
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu Z, Zhao J, et al. Epidemiology and molecular characterizations of azole resistance in clinical and environmental Aspergillus fumigatus isolates from China. Antimicrob Agents Chemother. 2016;60(10):5878–5884. doi:10.1128/AAC.01005-1627431231
   PubMed Web of Science ®Google Scholar
• Pinto E, Monteiro C, Maia M, et al. Aspergillus species and antifungals susceptibility in clinical setting in the North of Portugal: cryptic species and emerging azoles resistance in A. fumigatus. Front Microbiol. 2018;9:1656. doi:10.3389/fmicb.2018.0165630083151
   PubMed Web of Science ®Google Scholar
• Deng S, Zhang L, Ji Y, et al. Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China. Emerg Microbes Infect. 2017;6(12):e109. doi:10.1038/emi.2017.9729209054
   PubMed Web of Science ®Google Scholar
• Bank S, Christensen K, Kristensen LH, Prag J. A cost-effectiveness analysis of identifying Fusobacterium necrophorum in throat swabs followed by antibiotic treatment to reduce the incidence of Lemierre’s syndrome and peritonsillar abscesses. Eur J Clin Microbiol Infect Dis. 2013;32(1):71–78. doi:10.1007/s10096-012-1715-622886057
   PubMed Web of Science ®Google Scholar
• Iatta R, Nuccio F, Immediato D, et al. Species distribution and in vitro azole susceptibility of Aspergillus section Nigri isolates from clinical and environmental settings. J Clin Microbiol. 2016;54(9):2365–2372. doi:10.1128/JCM.01075-1627413191
   PubMed Web of Science ®Google Scholar
• Lackner M, Hagen F, Meis JF, et al. Susceptibility and diversity in the therapy-refractory genus scedosporium. Antimicrob Agents Chemother. 2014;58(10):5877–5885. doi:10.1128/AAC.03211-1425070092
   PubMed Web of Science ®Google Scholar
• Peterson SW. Phylogenetic analysis of Aspergillus species using DNA sequences from four loci. Mycologia. 2008;100(2):205–226. doi:10.1080/15572536.2008.1183247718595197
   PubMed Web of Science ®Google Scholar
• Siqueira JP, Sutton DA, Gene J, et al. Multilocus phylogeny and antifungal susceptibility of Aspergillus section Circumdati from clinical samples and description of A. pseudosclerotiorum sp. nov. J Clin Microbiol. 2017;55(3):947–958. doi:10.1128/JCM.02012-1628053212
   PubMed Web of Science ®Google Scholar
• CLSI. 2017 Reference Method for Broth Dilution Antifungal Susceptibility Testing of fIlamentous Fungi. CLSI Standard M38. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Espinel-Ingroff A, Fothergill A, Fuller J, Johnson E, Pelaez T, Turnidge J. Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother. 2011;55(6):2855–2859. doi:10.1128/AAC.01730-1021422219
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Chowdhary A, Gonzalez GM, et al. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method. Antimicrob Agents Chemother. 2013;57(8):3823–3828. doi:10.1128/AAC.00636-1323716059
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Diekema DJ, Fothergill A, et al. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). J Clin Microbiol. 2010;48(9):3251–3257. doi:10.1128/JCM.00536-1020592159
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Cuenca-Estrella M, Fothergill A, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother. 2011;55(11):5150–5154. doi:10.1128/AAC.00686-1121876047
   PubMed Web of Science ®Google Scholar
• Ozmerdiven GE, Ak S, Ener B, et al. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey. J Infect Chemother. 2015;21(8):581–586. doi:10.1016/j.jiac.2015.04.01226048062
   PubMed Web of Science ®Google Scholar
• Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23(21):2947–2948. doi:10.1093/bioinformatics/btm40417846036
   PubMed Web of Science ®Google Scholar
• Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017;3:4.
   Google Scholar
• Walker TA, Lockhart SR, Beekmann SE, et al. Recognition of azole-resistant aspergillosis by physicians specializing in infectious diseases, United States. Emerg Infect Dis. 2018;24:1. doi:10.3201/eid2401.170971
   Web of Science ®Google Scholar
• Ashu EE, Xu J. Strengthening the one health agenda: the role of molecular epidemiology in Aspergillus threat management. Genes. 2018;9(7). doi:10.3390/genes9070359
   Web of Science ®Google Scholar
• Cahill BC, Hibbs JR, Savik K, et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest. 1997;112(5):1160–1164. doi:10.1378/chest.112.5.11609367451
   PubMed Web of Science ®Google Scholar
• Barberan J, Garcia-Perez FJ, Villena V, et al. Development of aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp. BMC Infect Dis. 2017;17(1):34. doi:10.1186/s12879-016-2143-528056830
   PubMed Web of Science ®Google Scholar
• Yan X, Li M, Jiang M, Zou LQ, Luo F, Jiang Y. Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer. 2009;115(21):5018–5025. doi:10.1002/cncr.2455919637340
   PubMed Web of Science ®Google Scholar
• Liao Y, Chen M, Hartmann T, Yang RY, Liao WQ. Epidemiology of opportunistic invasive fungal infections in China: review of literature. Chin Med J. 2013;126(2):361–368.23324290
   PubMed Web of Science ®Google Scholar
• Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol. 2013;51(4):361–370. doi:10.3109/13693786.2012.73831223210682
   PubMed Web of Science ®Google Scholar
• Greenberger PA, Bush RK, Demain JG, Luong A, Slavin RG, Knutsen AP. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2014;2(6):703–708. doi:10.1016/j.jaip.2014.08.00725439360
   PubMed Web of Science ®Google Scholar
• Fang ZG, Ouyang ZY, Liu P, Sun L, Wang XY. Airborne fungal community composition in indoor environments in Beijing. Huan Jing Ke Xue. 2013;34(5):2031–2037.23914564
   PubMedGoogle Scholar
• Hu J, Li N, Lv Y, Liu J, Xie J, Zhang H. Investigation on indoor air pollution and childhood allergies in households in Six Chinese Cities by subjective survey and field measurements. Int J Environ Res Public Health. 2017;14:9. doi:10.3390/ijerph14090979
   Web of Science ®Google Scholar
• Gomez-Lopez A, Garcia-Effron G, Mellado E, Monzon A, Rodriguez-Tudela JL, Cuenca-Estrella M. In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 2003;47(10):3085–3088. doi:10.1128/AAC.47.10.3085-3088.200314506013
   PubMed Web of Science ®Google Scholar
• Rudramurthy SM, Paul RA, Chakrabarti A, Mouton JW, Meis JF. Invasive aspergillosis by Aspergillus flavus: epidemiology, diagnosis, antifungal resistance, and management. J Fungi (Basel). 2019;5:3.
   Google Scholar
• Rudramurthy SM, Singh G, Hallur V, Verma S, Chakrabarti A. High fungal spore burden with predominance of Aspergillus in hospital air of a tertiary care hospital in Chandigarh. Indian J Med Microbiol. 2016;34(4):529–532. doi:10.4103/0255-0857.19535927934837
   PubMed Web of Science ®Google Scholar
• Wang W, Zhao CY, Zhou JY, et al. Invasive pulmonary aspergillosis in patients with HBV-related liver failure. Eur J Clin Microbiol Infect Dis. 2011;30(5):661–667. doi:10.1007/s10096-010-1137-221197619
   PubMed Web of Science ®Google Scholar
• Severo LC, Geyer GR, Porto Nda S, Wagner MB, Londero AT. Pulmonary Aspergillus niger intracavitary colonization. Report of 23 cases and a review of the literature. Rev Iberoam Micol. 1997;14(3):104–110.17655384
   PubMedGoogle Scholar
• Bongomin F, Batac CR, Richardson MD, Denning DW. A review of onychomycosis due to Aspergillus species. Mycopathologia. 2018;183(3):485–493. doi:10.1007/s11046-017-0222-929147866
   PubMed Web of Science ®Google Scholar
• Frisvad JC, Hubka V, Ezekiel CN, et al. Taxonomy of Aspergillus section Flavi and their production of aflatoxins, ochratoxins and other mycotoxins. Stud Mycol. 2019;93:1–63. doi:10.1016/j.simyco.2018.06.00130108412
   PubMed Web of Science ®Google Scholar
• Alastruey-Izquierdo A, Mellado E, Pelaez T, et al. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother. 2013;57(7):3380–3387. doi:10.1128/AAC.00383-1323669377
   PubMed Web of Science ®Google Scholar
• Verweij PE, Lestrade PPA, Melchers WJG, Meis JF. Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased? J Antimicrob Chemother. 2016;71(8):2079–2082. doi:10.1093/jac/dkw25927494831
   PubMed Web of Science ®Google Scholar
• Shivaprakash MR, Geertsen E, Chakrabarti A, Mouton JW, Meis JF. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs. Mycoses. 2011;54(5):e583–e589. doi:10.1111/j.1439-0507.2010.01996.x21518026
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Garcia-Effron G, Monzon A, Rodriguez-Tudela JL. In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi. Antimicrob Agents Chemother. 2005;49(12):5136–5138. doi:10.1128/AAC.49.12.5136-5138.200516304186
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Boyken L, Hollis RJ, et al. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method. J Clin Microbiol. 2009;47(10):3323–3325. doi:10.1128/JCM.01155-0919710267
   PubMed Web of Science ®Google Scholar
• Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 1997;41(6):1364–1368. doi:10.1128/AAC.41.6.13649174200
   PubMed Web of Science ®Google Scholar
• Liu M, Zeng R, Zhang L, et al. Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China. Antimicrob Agents Chemother. 2015;59(7):4321–4325. doi:10.1128/AAC.00003-1525896700
   PubMed Web of Science ®Google Scholar
• Korfanty GA, Teng L, Pum N, Xu J. Contemporary gene flow is a major force shaping the Aspergillus fumigatus population in Auckland, New Zealand. Mycopathologia. 2019;184(4):479–492. doi:10.1007/s11046-019-00361-831309402
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ, Balajee SA. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother. 2011;55(9):4465–4468. doi:10.1128/AAC.00185-1121690285
   PubMed Web of Science ®Google Scholar
• van Ingen J, van der Lee HA, Rijs TA, et al. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands. J Antimicrob Chemother. 2015;70(1):178–181. doi:10.1093/jac/dku36425301884
   PubMed Web of Science ®Google Scholar
• Wiederhold NP, Patterson TF. Emergence of azole resistance in Aspergillus. Semin Respir Crit Care Med. 2015;36(5):673–680. doi:10.1055/s-0035-156289426398534
   PubMed Web of Science ®Google Scholar
• Hagiwara D, Watanabe A, Kamei K, Goldman GH. Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus fungi. Front Microbiol. 2016;7:1382. doi:10.3389/fmicb.2016.0138227708619
   PubMed Web of Science ®Google Scholar
• Kidd SE, Goeman E, Meis JF, Slavin MA, Verweij PE. Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses. 2015;58(6):350–355. doi:10.1111/myc.1232425885568
   PubMed Web of Science ®Google Scholar
• Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJ. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother. 2010;54(6):2425–2430. doi:10.1128/AAC.01599-0920385860
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Sharma C, van den Boom M, et al. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother. 2014;69(11):2979–2983. doi:10.1093/jac/dku25925006238
   PubMed Web of Science ®Google Scholar